Gynae BT_Lucknow_2018

Ongoing evidence for improving treatment planning – EMBRACE II

• Initiative EMBRACE study group within GEC-ESTRO • Start inclusion 2016, 1000 patients intended • Aims for EBRT and brachytherapy • Exclusive IMRT • SIB boosting for lymph node metastases • Extension elective field based on defined risk profile